| Kathryn A Kraus, PA-C | |
|
4110 Warrensville Center Rd, Beachwood, OH 44122-7024 | |
| (216) 491-6000 | |
| Not Available |
| Full Name | Kathryn A Kraus |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 20 Years |
| Location | 4110 Warrensville Center Rd, Beachwood, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114900560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 50-002225 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cleveland Clinic | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cleveland Clinic Foundation | 1850203555 | 5690 |
News Archive
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
Researchers from the Sinai Center for Thrombosis Research presented findings from a Phase 2a trial substudy that examined the antiplatelet effects of CSL112, a novel apolipoprotein A-I (apo A-I) infusion therapy, at the American Heart Association 2013 Scientific Sessions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the signing of a global settlement agreement among Alnylam, Max Planck Society ("Max Planck"), the Whitehead Institute for Biomedical Research ("Whitehead") and the University of Massachusetts ("UMass") resolving their ongoing litigation regarding the Tuschl patents.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
An unusual eating disorder that many people have never even heard of is attracting attention because of a recent government study that indicated the disorder is on the rise in the United States.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathryn A Kraus, PA-C Po Box 74647, Cleveland, OH 44194-0730 Ph: (440) 879-0081 | Kathryn A Kraus, PA-C 4110 Warrensville Center Rd, Beachwood, OH 44122-7024 Ph: (216) 491-6000 |
News Archive
Archimedes Inc., a healthcare modeling company, announced today that it has entered into a Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to develop a computer model of clinical trials evaluating weight loss medications. The model will be used to obtain a better understanding of the benefits of weight loss against the long-term risks of cardiovascular outcomes in patients treated with weight loss drugs.
Researchers from the Sinai Center for Thrombosis Research presented findings from a Phase 2a trial substudy that examined the antiplatelet effects of CSL112, a novel apolipoprotein A-I (apo A-I) infusion therapy, at the American Heart Association 2013 Scientific Sessions.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, today announced the signing of a global settlement agreement among Alnylam, Max Planck Society ("Max Planck"), the Whitehead Institute for Biomedical Research ("Whitehead") and the University of Massachusetts ("UMass") resolving their ongoing litigation regarding the Tuschl patents.
Representing small and medium-sized companies, Ian Staples, Chief Executive of British biotech Matoke Holdings, called on the House of Lords Science and Technology Committee to help ensure that life-saving drugs can get through the regulatory process faster. The Committee was taking evidence as part of its ‘Life Sciences and the Industrial Strategy' inquiry.
An unusual eating disorder that many people have never even heard of is attracting attention because of a recent government study that indicated the disorder is on the rise in the United States.
› Verified 8 days ago
Miss Alysse Jayne Boyd, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3909 Orange Pl Ste 3200, Beachwood, OH 44122 Phone: 216-342-2688 | |
Frankie Elizabeth Waller, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4110 Warrensville Center Rd, Beachwood, OH 44122 Phone: 216-491-6000 | |
Leah Fulton, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3401 Enterprise Pkwy, Suite 300, Beachwood, OH 44122 Phone: 216-831-5700 | |
Michelle Lynn James, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3401 Enterprise Pkwy, Suite 300, Beachwood, OH 44122 Phone: 216-831-5700 Fax: 216-831-1959 | |
Anthony J. Ciavarella, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 23250 Mercantile Rd, Suite 100, Beachwood, OH 44122 Phone: 216-831-7855 Fax: 216-831-5320 | |
Christopher C Rupprecht, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3755 Orange Pl Ste 101, Beachwood, OH 44122 Phone: 844-746-8537 Fax: 216-450-1810 |